Search

Search Constraints

You searched for: Author/Creator Helmer, Karl G.

Search Results

1. Baseline neuroimaging characteristics in the randomized pivotal study of renew NCP‐5 for the treatment of mild cognitive impairment (MCI) due to Alzheimer's disease or mild dementia of the Alzheimer's type. (December 2021)

2. Baseline neuroimaging characteristics in the randomized pivotal study of renew NCP‐5 for the treatment of mild cognitive impairment (MCI) due to Alzheimer's disease or mild dementia of the Alzheimer's type. (1st February 2022)

3. Demonstration of nonlinearity bias in the measurement of the apparent diffusion coefficient in multicenter trials. Issue 3 (2nd May 2015)

4. DT‐02‐05: MARKVCID PHASE II: PRIORITIZED CANDIDATE SMALL VESSEL VCID BIOMARKERS SELECTED FOR INDEPENDENT MULTI‐SITE TESTING AND VALIDATION. (1st July 2006)

5. MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols. Issue 4 (21st January 2021)

6. MarkVCID cerebral small vessel consortium: II. Neuroimaging protocols. Issue 4 (21st January 2021)

7. MRI free water as a biomarker for cognitive performance: Validation in the MarkVCID consortium. Issue 1 (13th December 2022)